US Patent 8449890 Neprilysin inhibitors
Patent 8449890 was granted and assigned to Theravance on May, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+84 characters)
Article
Patent abstract
In one aspect, the invention relates to compounds having the formula:
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Adam D. Hughes0
Cameron Smith0
Melissa Fleury0
Roland Gendron0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08449890 Neprilysin inhibitors US Patent 8449890 Neprilysin inhibitors
Infobox
Patent Number
084498900
Patent Number
84498900
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084498900
Date of Patent
May 28, 2013
0Patent Application Number
133980270
Date Filed
February 16, 2012
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08449890 Neprilysin inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08449890
Date of patent
May 28, 2013
Patent application number
13398027
Date Filed
February 16, 2012
Patent primary examiner
Find more entities like US Patent 8449890 Neprilysin inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.